Drug Design Reviews – Online

ISSN: 1567-2697 Volume 2, 2005

Editor-in-Chief:

Atta-ur-Rahman

HEJ Research Institute of Chemistry,
University of Karachi,
Karachi-75270,
Pakistan

Matthew Honan

Bentham Science Publishers Ltd.,
The Netherlands

Editorial Advisory Board:

W.-R. Abraham (GBF – N.R.C.B, Braunschweig, Germany)

J.D. Adams (Univ. of Southern California, LA, CA, USA)

V. Apostolopoulos (The Austin Res. Inst., Heidelberg, Australia)

S. Balaz (North Dakota State University, Fargo, ND, USA)

M. Balazy (New York Medical College, Valhalla, NY, USA)

T. Balla (Unit of Molec. Signal Transd., NICHD, Behtesda, MD, USA)

W.A. Banks (VAMC & Saint Louis University, MO, USA)

F.C. Barone (GlaxoSmithKline, King of Prussia, PA, USA)

N.H. Bell (Medical University of South Carolina, Charleston, SC, USA)

J.A. Beutler (Molecular Targets Dev. Program, Frederick, MD, USA)

M. Binaschi (Menarini Ricerche, Pomezia, Rome, Italy)

D.H. Boschelli (Wyeth Research, Pearl River, NY, USA)

J. Bremner (University of Pennsylvania, Pennsylvania, USA)

A.I. Bush (Massachusetts Gen. Hosp. East, Charlestown, MA, USA)

S.X. Cai (Maxim Pharmaceuticals, San Diego, CA, USA)

D. J. Canney (Temple University, Philadelphia, PA, USA)

S.J. Caradonna (Univ.of Med. and Dent. of NJ, Stratford, NJ, USA)

B.K. Cassels (University of Chile, Santiago, Chile)

M. Charton (The Clinton Hill CampusDeKalb Ave, NY, USA)

S.B. Christensen (The Danish Univ. of Pharm. Sci., Copenhagen, Denmark)

B.G. Christensen (Chanticleer Lane, Alamo, California, USA)

M.J.C. Crabbe (University of Reading, Reading, UK)

M. Crider (Southern Illinois University Edwardsville, Edwardsville, IL, USA)

P.A. Crooks (Univ. of Kentucky, Lexington, KY, USA)

V.J. Demopoulos (Aristotle Univ of Thessaloniki, Thessaloniki, Greece)

H.-U. Demuth (Probiodrug AG, Halle (Saale), Germany)

M. Dukat (Virginia Commonwealth Univ., Richmond, Virginia, USA)

C.G.-Echeverria (Novartis Pharma AG, Basel, Switzerland)

G. Ecker (University of Vienna, Vienna, Austria)

T.J. Egan (University of Cape Town, Rondebosch, South Africa)

P. Englebienne (Biomedical Consultant, Zingem, Belgium)

E. Estrada (Univ. of Santiago de Compostela, Santiago de Compostela, Spain)

R. Evans (Monash University, Victoria, Australia)

A.D. Everett (Univ. of Virginia Health System, Charlottesville, VA, USA)

E.I. Ferreira (Universidade de São Paulo, SP, Brazil)

P.M. Fischer (University of Nottingham, Nottingham, UK)

F. Focher (Instituto di Genetica Molecolare, PAVIA, Italy)

M. Fraziano (University of Rome "Tor Vergata", Rome, Italy)

F.K. Friedman (National Cancer Institute, NIH, Bethesda MS, USA)

D.M. Freymann (Northwestern University, Chicago, IL, USA)

R. Gambari (Ferrara University, Ferrara, Italy)

R.D. Gandour (Virginia Tech, Blacksburg, VA, USA)

I.S. –García (University of Salamanca, Salamanca, Spain)

D.S. Garvey (NitroMed Incorporated, Bedford, MA, USA)

R.C. -Gaudreault (Centre Hosp.Univ. e Québec,Québec, Canada)

V. Geenen (Univ. of Liege-Center of Immu., Liege, Belgium)

S.S. Gill (Health Canada, Ottawa, Canada)

U. Haberkorn (Univ. of Heidelberg, Heidelberg, Germany )

W.B. Harnett (University of Strathclyde, Glasgow, UK)

V.J. Hruby (University of Arizona, Tucson, Arizona)

A.P. IJzerman (Leiden University/LACDR, Leiden, The Netherlands)

K.-T. Jeang (Molec.Virology Sec., NIH, Bethesda, MD, USA)

W. Jelkmann (University of Luebeck, Luebeck, Germany)

A.Y. Jeng (Novartis Pharmaceuticals Corp., NJ, USA)

L. Jennings (University of Tennessee Memphis, TN, USA)

E. Jirillo (Univeristy of Bari, Bari, Italy)

T.I. Kalman ((University at Buffalo, Amherst, NY, USA)

W.M. Kazmierski (GlaxoSmithKline Research & Development, NC, USA)

J.F.W. Keana (University of Oregon, Eugene, OR, USA)

S.M. Kerwin (The Univ. of Texas at Austin, Austin, TX, USA)

M.-P. Kieny (Initiative for Vaccine Research WHO/IVR, Genève )

D.H. Kim (Pohang University of Science and Technolgy, Pohang, Korea)

D. Kirchhofer (Genentech, Inc. South San Francisco, CA, USA)

Y. Kiso (Kyoto Pharmaceutical University, Kyoto, Japan)

J. Kukkonen (Uppsala University, Uppsala, Sweden)

K. Kuwano (Kyushu University, Fukuoka, Japan)

U. Langel (Stockholm Univ., Stockholm, Sweden)

R.J. Leadley (Pfizer Global Research and Develop. Lab, MI, USA)

M. Lee (Furman University, Greenville, SC, USA)

S.E. Lipshultz (University of Miami, Miami, FL , USA)

J.W. Lown (University of Alberta, Alberta, Canada)

A. MacKerell (School of Pharmacy, Baltimore, MD, USA)

K. Maiese (Wayne State University, School of Medicine, Detroit, MI, USA)

W. F. Mangel (Brookhaven National Lab., New York, USA)

A. P. Marchand (University of North Texas, Denton, TX, USA)

A. Martinez (University of Bergen, Bergen, Norway)

T. Mavromoustakos (National Hellenic Research Foundation, Athens, Greece)

R. F. Meredith (Univ. of Alabama at Birmingham, Birmingham, AL, USA)

N.G. Morgan (Peninsula Medical School, Devon, UK)

K. Nakanishi (Columbia University, NY, USA)

A.H. Newman (NIH, Baltimore, Maryland, USA)

J. L. Neumeyer (Harvard Medical School, Belmont, MA, USA)

V.C.O. Njar (University of Maryland, Baltimore, MD, USA)

T. Ochiya (National Cancer Center Res. Inst., Tokyo, Japan)

A.G. Papavassiliou (University of Patras, Patras, Greece)

A.F. Para (CTR DE Invest Esrudios AVE IPN, Mexico, USA)

D. Poirier (Université Laval, Québec, Canada)

G. Poli (Vita-Salute San Raffaele University, Milano, ITALY)

M.G. Pomper (Johns Hopkins Univ. School of Med., Baltimore, MD, USA)

M. Rademaker (School of Medicine, Christchurch, New Zealand)

D. Ribatti (Univeristy of Bari Medical School, Bari, Italy)

K.C. Rice (National Institutes of Health, Bethesda, MD, USA)

V. Rotello (University of Massachusetts, Amherst, MA, USA)

J. Russo (Fox Chase Cancer Center, Philadelphia Pennsylvania, USA)

T.K. Sawyer (ARIAD Pharma., Cambridge, MA, USA)

D.J. Schneider (University of Vermont, Colchester, VT, USA)

C.H. Selzman (University of North Carolina, Chapel Hill, NC, USA)

S.P. Sheikh (Univ. of Copenhagen, Copenhagen, Denmark)

J.S. Skotnicki (Wyeth Research, NY, USA)
A.T. Sneden (Virginia Commonwealth University, Richmond, VA, USA)

K. Steliou (Boston University, Boston, MA, USA)

H.U. Stilz (Aventis Pharma Deutschland, Frankfurt, Germany)

K. Takeuchi (Kyoto Pharmaceutical University, Kyoto, Japan)

S. Takai (Osaka Medical College, Osaka, Japan)

S.W. Topiol (Novartis Institutes for Biomedical Research, NJ, USA)

I. Toth (University of Queensland, Brisbane, Australia)

J.A. Towbin (Baylor College of Medicine, Houston, TX, USA)

A. Tropsha (University of North Carolina, NC, USA)

F.M. Uckun (Parker Hughes Institute, Minnesota, USA)

R. Volpe (Rosedale Medical Center, Toronto Ontario, Canada)

C.R. Wagner (University of Minnesota, Minneapolis, MN, USA)

V. Weissig (Northeastern University, Boston, MA, USA)

P. Wentworth (The Scripps Res. Inst., La Jolla, CA, USA)

W.J. Wheeler (Eli Lilly and Co., Indianapolis, IN, USA)

M. Wiese (Institution University of Bonn, Bonn, Germany)

M.V. Williams (The Ohio State University, Columbus, OH, USA)

J.S. Williamson (University of Mississippi, University, MS, USA)

P. Workman (Institute of Cancer Research, Sutton, UK)

Z. Xing (Health Sciences Centre Mc Master Univ. Ontario, Canada)

S.-Y. Ying (University of South. California, Los Angeles, CA, USA)

M. Yoshizumi (Nara Medical University School of Medicine, Nara, Japan)

Z.-Y. Zhang (Albert Einstein College of Medicine, NY, USA)

R. Zhang (Univ. of Alabama at Birmingham, Birmingham AL, USA)

F. Zunino (Istituto Nazionale Tumori, Milan, Italy)